News articles

News article list

• NICE and NHS England announce plan to enable innovative tech to be adopted quicker

  NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies under new plans.

• Home testing devices could increase the number of people diagnosed with sleep apnoea

  Five home-testing devices to diagnose a silent sleep condition harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.

• New tests could spare people with early breast cancer from unnecessary chemotherapy

  More people with early breast cancer could be spared chemotherapy and therefore avoid the side effects associated with the treatment after tumour profiling tests were recommended by NICE.

• Around 4,000 people with sickle cell disease could benefit from a new treatment recommended by NICE

  Improved deal signals NICE recommendation of sickle cell treatment voxelotor.

• New life-extending drug treatment for children and teenagers with an aggressive form of brain cancer

  Dabrafenib with trametinib is a targeted treatment that can be taken at home rather than hospital and improves the length and quality of life for patients..

• 170,000 people in England to have further treatment choice for preventing migraine attacks

  In final draft guidance published today NICE has recommended atogepant, the first of a new type of oral treatment option for preventing both chronic and episodic migraines, opening the way for up to 170,000 people to choose it on the NHS in England.